Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer.

JAMA network open·2026

Same author

Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles".

ACS central science·2026

Same author

X-ray activated platinum complex induces DNA damage and enhances cancer immunotherapy through abscopal effect.

Nature biomedical engineering·2026

Same author

Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates.

Clinical genitourinary cancer·2025

Same author

Neuronal Membrane-Functionalized Biohybrid Microrobots for Active Decontamination of Neurotoxins in Aqueous Environments.

ACS nano·2025

Same author

Efficacious suppression of primary and metastasized liver tumors by polyIC-loaded lipid nanoparticles.

Hepatology (Baltimore, Md.)·2025

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Biofunctionalized targeted nanoparticles for therapeutic applications.

Andrew Z Wang¹, Frank Gu, Liangfang Zhang

¹Department of Anesthesiology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.

Expert Opinion on Biological Therapy

|July 11, 2008

Summary

This summary is machine-generated.

Targeted nanoparticles enhance medical treatment by delivering therapeutics directly to diseased tissues. Biofunctionalized nanoparticles show promise for maximizing drug efficacy and minimizing side effects on healthy cells.

More Related Videos

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Experiment Videos

Last Updated: Jul 3, 2026

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Area of Science:

Biomedical Engineering
Nanotechnology
Drug Delivery Systems

Background:

Nanoparticle development offers new avenues for improving medical treatments.
Targeted nanoparticles are engineered by attaching targeting molecules (e.g., antibodies, peptides) to their surfaces for precise therapeutic delivery.

Purpose of the Study:

To provide a comprehensive review of the current advancements in targeted nanoparticle development for therapeutic applications.

Main Methods:

Discussion of various nanoparticle platforms suitable for therapeutic delivery.
Analysis of different targeting molecules used for nanoparticle functionalization.
Overview of biofunctionalized targeted nanoparticles currently under investigation.

Main Results:

Biofunctionalized targeted nanoparticles have yielded promising outcomes in preclinical research.
These advanced nanoparticles demonstrate potential for enhanced therapeutic efficacy.

Conclusions:

Targeted nanoparticles represent a significant advancement in drug delivery.
Continued development may enable these carriers to optimize drug concentration in diseased tissues while sparing healthy cells.